Falecalcitriol
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-Methyl-1-[(2R)-7,7,7-trifluoro-6-hydroxy-6-(trifluoromethyl)heptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| Legal status |
|
| Identifiers | |
| CAS Number |
83805-11-2 |
| ATC code | none |
| PubChem | CID 5282190 |
| IUPHAR/BPS | 2781 |
| ChemSpider |
4445383 |
| UNII |
G70A8514T8 |
| KEGG |
D01662 |
| ChEMBL | CHEMBL2106158 |
| Chemical data | |
| Formula | C27H38F6O3 |
| Molar mass | 524.57 g/mol |
| |
| |
| | |
Falecalcitriol (INN) is an analog of calcitriol. It has a higher potency both in vivo and in vitro systems, and longer duration of action in vivo.[1]
References
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
